Effects of CB 1 and CRF 1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: Lack of withdrawal-like responses

Physiology and Behavior

Volumn 107, Issue 2, 2012, Pages 231-242

  Parylak, Sarah L ^a,b   Cottone, Pietro ^a,c   Sabino, Valentina ^a,c   Rice, Kenner C ^d   Zorrilla, Eric P ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Binge eating; Corticotropin releasing factor or corticotropin releasing hormone or CRF or CRH; Endocannabinoid or cannabinoid type 1 receptor; Obesity; Palatable food intake; Sucrose or sugar or fat or food addiction; Surinabant or rimonabant; Withdrawal anxiety

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; CANNABINOID 1 RECEPTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; SUCROSE; SURINABANT; CANNABINOID RECEPTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; APPETITE; ARTICLE; BINGE EATING DISORDER; CALORIC INTAKE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FAT INTAKE; FEMALE; FOOD INTAKE; HORMONE RESPONSE; IMMOBILIZATION STRESS; LOCOMOTION; MAZE TEST; NONHUMAN; OBESITY; PALATABILITY; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; SUGAR INTAKE; WEIGHT GAIN; WITHDRAWAL SYNDROME; ANIMAL; BLOOD; BULIMIA; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; WISTAR RAT;

ANIMALS; ANXIETY; BULIMIA; CANNABINOID RECEPTOR ANTAGONISTS; CORTICOSTERONE; DIETARY FATS; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MAZE LEARNING; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 84864518531     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.06.017     Document Type: Article

References (82)

1. Allison S., Timmerman G.M. Anatomy of a binge: food environment and characteristics of nonpurge binge episodes. Eat Behav 2007, 8:31-38.
2. Avena N.M., Bocarsly M.E., Rada P., Kim A., Hoebel B.G. After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Physiol Behav 2008, 94:309-315.
3. Berner L.A., Avena N.M., Hoebel B.G. Bingeing, self-restriction, and increased body weight in rats with limited access to a sweet-fat diet. Obesity (Silver Spring) 2008, 16:1998-2002.
4. Boggiano M.M., Chandler P.C. Binge eating in rats produced by combining dieting with stress. Curr Protoc Neurosci 2006, 36. 9.23A.1-8.
5. Corwin R.L., Wojnicki F.H. Binge eating in rats with limited access to vegetable shortening. Curr Protoc Neurosci 2006, 36. 9.23B.1-11.
6. Wojnicki F.H., Charny G., Corwin R.L. Binge-type behavior in rats consuming trans-fat-free shortening. Physiol Behav 2008, 94:627-629.
7. Cottone P., Sabino V., Steardo L., Zorrilla E.P. Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Neuropsychopharmacology 2008, 33:524-535.
8. DesMaisons K. The sugar addict's total recovery program 2002, Ballantine Books.
9. Dufty W. Sugar blues 1986, Grand Central Publishing.
10. Lustig R.H., Schmidt L.A., Brindis C.D. Public health: the toxic truth about sugar. Nature 2012, 482:27-29.
11. Colantuoni C., Rada P., McCarthy J., Patten C., Avena N.M., Chadeayne A., et al. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 2002, 10:478-488.
12. Cottone P., Sabino V., Roberto M., Bajo M., Pockros L., Frihauf J.B., et al. CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci U S A 2009, 106:20016-20020.
13. Cottone P., Sabino V., Steardo L., Zorrilla E.P. Consummatory, anxiety-related and metabolic adaptations in female rats with alternating access to preferred food. Psychoneuroendocrinology 2009, 34:38-49.
14. Teegarden S.L., Bale T.L. Decreases in dietary preference produce increased emotionality and risk for dietary relapse. Biol Psychiatry 2007, 61:1021-1029.
15. Bocarsly M.E., Berner L.A., Hoebel B.G., Avena N.M. Rats that binge eat fat-rich food do not show somatic signs or anxiety associated with opiate-like withdrawal: implications for nutrient-specific food addiction behaviors. Physiol Behav 2011, 104:865-872.
16. Waters A., Hill A., Waller G. Internal and external antecedents of binge eating episodes in a group of women with bulimia nervosa. Int J Eat Disord 2001, 29:17-22.
17. Hagan M.M., Chandler P.C., Wauford P.K., Rybak R.J., Oswald K.D. The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eating. Int J Eat Disord 2003, 34:183-197.
18. Timofeeva E., Baraboi E.D., Poulin A.M., Richard D. Palatable high-energy diet decreases the expression of cannabinoid type 1 receptor messenger RNA in specific brain regions in the rat. J Neuroendocrinol 2009, 21:982-992.
19. Izzo A.A., Piscitelli F., Capasso R., Aviello G., Romano B., Borrelli F., et al. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol 2009, 158:451-461.
20. DiPatrizio N.V., Simansky K.J. Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats. J Neurosci 2008, 28:9702-9709.
21. Foster M.T., Warne J.P., Ginsberg A.B., Horneman H.F., Pecoraro N.C., Akana S.F., et al. Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint. Endocrinology 2009, 150:2325-2333.
22. la Fleur S.E., Houshyar H., Roy M., Dallman M.F. Choice of lard, but not total lard calories, damps adrenocorticotropin responses to restraint. Endocrinology 2005, 146:2193-2199.
23. Pecoraro N., Reyes F., Gomez F., Bhargava A., Dallman M.F. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 2004, 145:3754-3762.
24. Ulrich-Lai Y.M., Christiansen A.M., Ostrander M.M., Jones A.A., Jones K.R., Choi D.C., et al. Pleasurable behaviors reduce stress via brain reward pathways. Proc Natl Acad Sci U S A 2010, 107:20529-20534.
25. Ulrich-Lai Y.M., Ostrander M.M., Thomas I.M., Packard B.A., Furay A.R., Dolgas C.M., et al. Daily limited access to sweetened drink attenuates hypothalamic-pituitary-adrenocortical axis stress responses. Endocrinology 2007, 148:1823-1834.
26. Dallman M.F., Pecoraro N., Akana S.F., La Fleur S.E., Gomez F., Houshyar H., et al. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci U S A 2003, 100:11696-11701.
27. Hudson J.I., Hiripi E., Pope H.G., Kessler R.C. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007, 61:348-358.
28. Chen C., Wilcoxen K.M., Huang C.Q., Xie Y.F., McCarthy J.R., Webb T.R., et al. Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]py rimidine (NBI 30775/R121919) and structure-activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. J Med Chem 2004, 47:4787-4798.
29. Rinaldi-Carmona M., Barth F., Congy C., Martinez S., Oustric D., Perio A., et al. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3 -carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 2004, 310:905-914.
30. Rivier J., Amoss M., Rivier C., Vale W. Synthetic luteinizing hormone releasing factor. Short chain analogs. J Med Chem 1974, 17:230-233.
31. Zorrilla E.P., Valdez G.R., Nozulak J., Koob G.F., Markou A. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 2002, 952:188-199.
32. Arnone M., Maruani J., Chaperon F., Thiebot M.H., Poncelet M., Soubrie P., et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1997, 132:104-106.
33. Navarro M., Hernandez E., Munoz R.M., del Arco I., Villanua M.A., Carrera M.R., et al. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 1997, 8:491-496.
34. Aceto M.D., Scates S.M., Lowe J.A., Martin B.R. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol 1995, 282:R1-R2.
35. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979, 86:420-428.
36. Rosner B. Fundamentals of biostatistics 1995, Duxbury Press, Boston, MA.
37. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 2006, 189:175-186.
38. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 2007, 61:78-86.
39. Gilpin N.W., Richardson H.N., Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 2008, 32:1535-1542.
40. Richardson H.N., Zhao Y., Fekete E.M., Funk C.K., Wirsching P., Janda K.D., et al. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav 2008, 88:497-510.
41. Gehlert D.R., Cippitelli A., Thorsell A., Le A.D., Hipskind P.A., Hamdouchi C., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 2007, 27:2718-2726.
42. Greenwell T.N., Funk C.K., Cottone P., Richardson H.N., Chen S.A., Rice K.C., et al. Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addict Biol 2009, 14:130-143.
43. George O., Ghozland S., Azar M.R., Cottone P., Zorrilla E.P., Parsons L.H., et al. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci U S A 2007, 104:17198-17203.
44. Specio S.E., Wee S., O'Dell L.E., Boutrel B., Zorrilla E.P., Koob G.F. CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) 2008, 196:473-482.
45. Avena N.M., Rada P., Hoebel B.G. Sugar and fat bingeing have notable differences in addictive-like behavior. J Nutr 2009, 139:623-628.
46. Ackroff K., Vigorito M., Sclafani A. Fat appetite in rats: the response of infant and adult rats to nutritive and non-nutritive oil emulsions. Appetite 1990, 15:171-188.
47. Lucas F., Sclafani A. Food deprivation increases the rat's preference for a fatty flavor over a sweet taste. Chem Senses 1996, 21:169-179.
48. Ramirez I. Stimulation of fluid intake by nutrients: oil is less effective than carbohydrate. Am J Physiol 1997, 272:R289-R293.
49. Ackroff K., Dym C., Yiin Y.M., Sclafani A. Rapid acquisition of conditioned flavor preferences in rats. Physiol Behav 2009, 97:406-413.
50. Lucas F., Sclafani A. Differential reinforcing and satiating effects of intragastric fat and carbohydrate infusions in rats. Physiol Behav 1999, 66:381-388.
51. Tracy A.L., Phillips R.J., Chi M.M., Powley T.L., Davidson T.L. The gastrointestinal tract "tastes" nutrients: evidence from the intestinal taste aversion paradigm. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1086-R1100.
52. Zukerman S., Ackroff K., Sclafani A. Rapid post-oral stimulation of intake and flavor conditioning by glucose and fat in the mouse. Am J Physiol Regul Integr Comp Physiol 2011, 301:R1635-R1647.
53. Sclafani A., Glendinning J.I. Sugar and fat conditioned flavor preferences in C57BL/6J and 129 mice: oral and postoral interactions. Am J Physiol Regul Integr Comp Physiol 2005, 289:R712-R720.
54. Balster R.L., Schuster C.R. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 1973, 20:119-129.
55. Corrigall W.A., Coen K.M. Fixed-interval schedules for drug self-administration in the rat. Psychopharmacology (Berl) 1989, 99:136-139.
56. Wakabayashi K.T., Weiss M.J., Pickup K.N., Robinson T.E. Rats markedly escalate their intake and show a persistent susceptibility to reinstatement only when cocaine is injected rapidly. J Neurosci 2010, 30:11346-11355.
57. Schindler C.W., Panlilio L.V., Thorndike E.B. Effect of rate of delivery of intravenous cocaine on self-administration in rats. Pharmacol Biochem Behav 2009, 93:375-381.
58. Liu Y., Roberts D.C., Morgan D. Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed. Eur J Neurosci 2005, 22:195-200.
59. Volkow N.D., Wang G.J., Fischman M.W., Foltin R., Fowler J.S., Franceschi D., et al. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci 2000, 67:1507-1515.
60. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004, 65(Suppl. 5):7-12.
61. Lodefalk M., Aman J., Bang P. Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with type 1 diabetes. Diabet Med 2008, 25:1030-1035.
62. Marciani L., Wickham M., Singh G., Bush D., Pick B., Cox E., et al. Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1607-G1613.
63. Gentilcore D., Chaikomin R., Jones K.L., Russo A., Feinle-Bisset C., Wishart J.M., et al. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab 2006, 91:2062-2067.
64. Welch I.M., Bruce C., Hill S.E., Read N.W. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for the dietary management of diabetes mellitus. Clin Sci (Lond) 1987, 72:209-216.
65. Horowitz M., Jones K.L., Rayner C.K., Read N.W. 'Gastric' hypoglycaemia-an important concept in diabetes management. Neurogastroenterol Motil 2006, 18:405-407.
66. Gutman D.A., Owens M.J., Skelton K.H., Thrivikraman K.V., Nemeroff C.B. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther 2003, 304:874-880.
67. Keck M.E., Welt T., Wigger A., Renner U., Engelmann M., Holsboer F., et al. The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats. Eur J Neurosci 2001, 13:373-380.
68. Koob G.F., Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 2005, 8:1442-1444.
69. Ghitza U.E., Gray S.M., Epstein D.H., Rice K.C., Shaham Y. The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology 2006, 31:2188-2196.
70. Ghitza U.E., Nair S.G., Golden S.A., Gray S.M., Uejima J.L., Bossert J.M., et al. Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J Neurosci 2007, 27:11522-11532.
71. Boggiano M.M., Dorsey J.R., Thomas J.M., Murdaugh D.L. The Pavlovian power of palatable food: lessons for weight-loss adherence from a new rodent model of cue-induced overeating. Int J Obes (Lond) 2009, 33:693-701.
72. Mistlberger R., Rusak B. Palatable daily meals entrain anticipatory activity rhythms in free-feeding rats: dependence on meal size and nutrient content. Physiol Behav 1987, 41:219-226.
73. Mendoza J., Angeles-Castellanos M., Escobar C. Entrainment by a palatable meal induces food-anticipatory activity and c-Fos expression in reward-related areas of the brain. Neuroscience 2005, 133:293-303.
74. Mistlberger R.E. Circadian food-anticipatory activity: formal models and physiological mechanisms. Neurosci Biobehav Rev 1994, 18:171-195.
75. Amsel A. The role of frustrative nonreward in noncontinuous reward situations. Psychol Bull 1958, 55:102-119.
76. Drobes D.J., Miller E.J., Hillman C.H., Bradley M.M., Cuthbert B.N., Lang P.J. Food deprivation and emotional reactions to food cues: implications for eating disorders. Biol Psychol 2001, 57:153-177.
77. Johnson P.M., Kenny P.J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010, 13:635-641.
78. Mathes C.M., Ferrara M., Rowland N.E. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats. Am J Physiol Regul Integr Comp Physiol 2008, 295:R67-R75.
79. Simiand J., Keane M., Keane P.E., Soubrie P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 1998, 9:179-181.
80. Jarrett M.M., Scantlebury J., Parker L.A. Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 2007, 90:425-430.
81. Verty A.N., McGregor I.S., Mallet P.E. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 2004, 354:217-220.
82. USDA Data tables: results from USDA's 1994-96 continuing survey of food intakes by individuals and 1994-96 diet and health knowledge survey 1999.